Accuracy
TBD
Speed
TBD
Sample of data set required for License Intelligence Agent:
Account Renewal Analysis Request
Sample output delivered by the License Intelligence Agent:
License Renewal Intelligence Report
Customer: Apex Solutions CRM ID: CUST-481516 Report Date: 2023-09-15 Analysis Period: June 1, 2023 - September 14, 2023
1. Executive Summary
Apex Solutions presents a High Risk for non-renewal for its upcoming 'Nexus Platform' licenses, with a calculated risk score of 7.8/10. Key indicators include a significant decline in active user engagement, a high volume of unresolved high-severity support tickets, and a recent late payment. The total Annual Recurring Revenue (ARR) at risk is $275,000. Immediate, strategic intervention is required to mitigate churn risk and secure this renewal.
2. Upcoming Renewal Portfolio
The following licenses are due for renewal within the next 90 days:
| License ID | Product | Seats | Expiry Date | Annual Recurring Revenue (ARR) |
|---|---|---|---|---|
| NEX-PROD-8812A | Nexus Platform Pro | 250 | 2023-11-30 | $150,000 |
| NEX-ENT-5509B | Nexus Platform Ent | 50 | 2023-12-15 | $125,000 |
| Total | $275,000 |
Risk Score: 7.8 / 10 (High Risk)
Usage Analytics:
Support Ticket Analysis:
Financial Health:
Contractual & Compliance:
Action Plan:
Generates concise, opportunity-specific summaries of insights, exceptions, and key actions for stakeholder review.
Automatically aggregates, validates, enriches, and standardizes sales data into complete, audit-ready opportunity profiles.
Analyzes consolidated sales data to calculate close rates, highlight performance patterns, and identify contributing factors.
Recommends optimal solution components aligned to finalized requirements using feasibility scoring, historical performance insights, and expert escalation.
Continuously monitors inbound communications to detect requirement changes, flag risks, and trigger timely team alerts.
Creates a unified, immutable proposal record with automated version control and comprehensive audit trails to support compliant approvals.